Evidence map›Paper›PMID 37266490›Full record

ArticleRSC advances2023

Effects of organoclay on colorless and transparent polyimide nanocomposites: thermomechanical properties, morphology, and optical transparency.

Yeji Na, Lee Ku Kwac, Hong Gun Kim, Yong Lak Joo, Jin-Hae Chang

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yeji NaGraduate School of Carbon Convergence Engineering, Jeonju University Jeonju 55069 Korea.
Lee Ku KwacGraduate School of Carbon Convergence Engineering, Jeonju University Jeonju 55069 Korea.
Hong Gun KimGraduate School of Carbon Convergence Engineering, Jeonju University Jeonju 55069 Korea.
Yong Lak JooRobert Fredrick Smith School of Chemical and Biomolecular Engineering, Cornell University Ithaca NY 14853 USA.ORCID https://orcid.org/0000-0002-4646-1625
Jin-Hae ChangInstitute of Carbon Technology, Jeonju University Jeonju 55069 Korea jhchang@jj.ac.kr.ORCID https://orcid.org/0000-0002-7323-9042

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although aromatic polyimide (PI) exhibits excellent mechanical performance and thermal stability, its dark color limits applicability in optical displays. Therefore, it is desirable to manufacture colorless, transparent PI (CPI) nanocomposite films that retain excellent physical properties. In this study, a solution intercalation method was used to disperse organoclay (Cloisite 25A; CS25A) in poly(amic acid), which was prepared using 4,4'-oxydiphthalic dianhydride and 3,4'-oxydianiline as monomers. This dispersion was then subjected to thermal imidization to synthesize CPI hybrid films. The influence of the CS25A content (0-1.00 wt%) on the thermomechanical properties, optical transmittance, and morphology of the prepared films was investigated. The hybrid film with a CS25A content of 0.50 wt% exhibited the best thermomechanical properties. However, upon further increasing the organoclay content to 1.00 wt%, the physical properties deteriorated. At 0.50 wt% CS25A, some agglomeration occurred but most of the clay was well dispersed as nano-sized particles, as revealed by transmission electron microscopy. In contrast, when the CS25A content exceeded a critical content, most of the clay was agglomerated and the physical properties were reduced. All the obtained CPI hybrid films were colorless and transparent, regardless of the organoclay content.

Identifiers

PMID37266490
PMCPMC10230512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.